R1 RCM Financials

RCM Stock  USD 14.31  0.01  0.07%   
Based on the analysis of R1 RCM's profitability, liquidity, and operating efficiency, R1 RCM Inc is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. At this time, R1 RCM's Accounts Payable is very stable compared to the past year. As of the 22nd of November 2024, Non Current Assets Total is likely to grow to about 4.5 B, though Net Tangible Assets are likely to grow to (1.2 B). Key indicators impacting R1 RCM's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.570.5973
Sufficiently Down
Slightly volatile
Current Ratio1.091.8293
Way Down
Very volatile
The essential information of the day-to-day investment outlook for R1 RCM includes many different criteria found on its balance sheet. An individual investor should monitor R1 RCM's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in R1 RCM.

Net Income

3.13 Million

  
Understanding current and past R1 RCM Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of R1 RCM's financial statements are interrelated, with each one affecting the others. For example, an increase in R1 RCM's assets may result in an increase in income on the income statement.

R1 RCM Stock Summary

R1 RCM competes with National Research, Definitive Healthcare, HealthStream, Evolent Health, and CareMax. R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. The company was founded in 2003 and is headquartered in Murray, Utah. R1 Rcm operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 20800 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS7493971052
CUSIP77634L105 749397105 00438V103
LocationIllinois; U.S.A
Business Address434 W Ascension
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.r1rcm.com
Phone312 324 7820
CurrencyUSD - US Dollar

R1 RCM Key Financial Ratios

R1 RCM Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets929.1M1.2B1.4B5.1B5.0B5.2B
Other Current Liab135.1M141.7M196M179.6M87.5M122.2M
Other Liab29M52.6M40.1M242.5M278.9M292.8M
Net Tangible Assets(399.8M)(207M)(473.4M)(1.5B)(1.3B)(1.2B)
Net Debt357.5M461.4M709.2M1.8B1.6B1.6B
Retained Earnings(277.8M)(161.5M)(64.3M)(121.9M)(136.7M)(143.5M)
Accounts Payable20.2M18.2M17.7M33.4M22.7M31.0M
Cash92M173.8M130.1M110.1M173.6M149.4M
Other Assets99.7M195M120.9M150.5M173.1M113.3M
Long Term Debt337.7M519.7M754.9M1.7B1.6B1.6B
Net Receivables83.1M122.2M162.9M344.1M379.5M398.5M
Good Will253.2M375.3M554.7M2.7B2.6B2.8B
Other Current Assets41.6M59.4M71.7M110.3M80.2M84.2M
Total Liab911M849.6M1.1B2.4B2.2B2.3B
Short Long Term Debt16.3M34.2M25.8M53.9M72.8M76.4M
Total Current Assets216.7M355.4M364.7M564.5M633.3M665.0M
Treasury Stock(62.6M)(73.6M)(139.2M)(215.2M)(193.7M)(184.0M)
Short Term Debt29.1M46.4M39.3M71.9M92.1M48.4M
Intangible Assets164.7M171.1M265.4M1.5B1.3B1.4B
Common Stock1.3M1.4M3M4.4M4.5M4.7M

R1 RCM Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense29.1M17.3M18.9M64M126.9M133.2M
Total Revenue1.2B1.3B1.5B1.8B2.3B2.4B
Gross Profit198.3M249.7M311.8M361.3M484.5M508.7M
Operating Income112.7M80M145.7M3M147.9M155.3M
Ebit112.7M135.7M145.7M3M147.9M155.3M
Ebitda168.4M211.7M223.2M175M426.2M447.5M
Cost Of Revenue987.8M1.0B1.2B1.4B1.8B1.9B
Income Before Tax9.8M118.4M126.8M(61M)21M39.3M
Net Income12M115.2M87.3M(57.6M)3.3M3.1M
Income Tax Expense(2.2M)1.3M29.6M(3.4M)17.7M16.0M
Tax Provision(2.2M)1.3M29.6M(3.4M)5.8M10.7M
Net Interest Income(29.1M)(17.3M)(18.9M)(64M)(124M)(117.8M)

R1 RCM Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash27.4M82.3M(44.7M)(20M)63.5M66.7M
Free Cash Flow52.9M12.5M213.1M(103.4M)237.6M249.5M
Depreciation55.7M68.7M77.5M172M278.3M292.2M
Other Non Cash Items34.8M(25.1M)9.3M57M74.1M77.8M
Capital Expenditures61M49.3M51.7M93.5M102.5M107.6M
Net Income12M117.1M97.2M(57.6M)3.3M3.1M
End Period Cash Flow92.5M174.8M130.1M110.1M173.6M149.7M
Change To Inventory(24.9M)(1.2M)(44M)(11.4M)(10.3M)(9.7M)
Dividends Paid13.7M18.4M8.9M2.6M1.3M1.2M
Change To Netincome32.4M(28.1M)95.4M113.7M130.8M137.3M
Change Receivables(39.1M)11.5M(56.5M)(33.2M)(29.9M)(28.4M)
Investments(61M)(117M)(340.4M)(949.5M)(103.2M)(108.4M)
Net Borrowings(7.2M)217.2M217.8M1.0B1.2B1.2B

RCM Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining R1 RCM's current stock value. Our valuation model uses many indicators to compare R1 RCM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across R1 RCM competition to find correlations between indicators driving R1 RCM's intrinsic value. More Info.
R1 RCM Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, R1 RCM's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value R1 RCM by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

R1 RCM Inc Systematic Risk

R1 RCM's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. R1 RCM volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on R1 RCM Inc correlated with the market. If Beta is less than 0 R1 RCM generally moves in the opposite direction as compared to the market. If R1 RCM Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one R1 RCM Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of R1 RCM is generally in the same direction as the market. If Beta > 1 R1 RCM moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in R1 RCM Stock are looking for potential investment opportunities by analyzing not only static indicators but also various R1 RCM's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of R1 RCM growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(12.14)

At this time, R1 RCM's Price Earnings To Growth Ratio is very stable compared to the past year.

R1 RCM November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of R1 RCM help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of R1 RCM Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of R1 RCM Inc based on widely used predictive technical indicators. In general, we focus on analyzing RCM Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build R1 RCM's daily price indicators and compare them against related drivers.
When determining whether R1 RCM Inc is a strong investment it is important to analyze R1 RCM's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact R1 RCM's future performance. For an informed investment choice regarding RCM Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in R1 RCM Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of R1 RCM. If investors know RCM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about R1 RCM listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(0.14)
Revenue Per Share
5.854
Quarterly Revenue Growth
0.147
Return On Assets
0.0235
The market value of R1 RCM Inc is measured differently than its book value, which is the value of RCM that is recorded on the company's balance sheet. Investors also form their own opinion of R1 RCM's value that differs from its market value or its book value, called intrinsic value, which is R1 RCM's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because R1 RCM's market value can be influenced by many factors that don't directly affect R1 RCM's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between R1 RCM's value and its price as these two are different measures arrived at by different means. Investors typically determine if R1 RCM is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, R1 RCM's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.